SCHEIN PHARMACEUTICAL, INC. – Trademark Portfolio
Entity Type: 03
SCHEIN PHARMACEUTICAL, INC. holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 5 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include INFED. The owner is based in FLORHAM PARK, NJ.
100 CAMPUS DRIVE
FLORHAM PARK, NJ 07932
Showing of trademarks Trademarks
Trademark Classifications
SCHEIN PHARMACEUTICAL, INC.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does SCHEIN PHARMACEUTICAL, INC. have?
SCHEIN PHARMACEUTICAL, INC. has 7 U.S. trademarks filed with the USPTO. Of these, 1 registered, 2 abandoned, 4 cancelled.
What trademark classes does SCHEIN PHARMACEUTICAL, INC. file in?
SCHEIN PHARMACEUTICAL, INC. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 35 (Advertising & Business), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are SCHEIN PHARMACEUTICAL, INC.'s most well-known trademarks?
SCHEIN PHARMACEUTICAL, INC.'s registered trademark portfolio includes well-known marks such as INFED. These are among 1 currently registered trademark in the portfolio.
What is SCHEIN PHARMACEUTICAL, INC.'s trademark registration success rate?
SCHEIN PHARMACEUTICAL, INC. has a 14% trademark registration rate, with 1 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.